Opioid Agonist Treatment: March 2020
The Correctional Service of Canada (CSC) introduced methadone over 20 years ago. Since that time, CSC has been providing opioid agonist treatment (OAT) (methadone and buprenorphine-naloxone) to incarcerated persons with an opioid use disorder.
Over the past three years, in the context of the Canadian opioid crisis, the demand for treatment has dramatically increased and continues to increase. The following graph shows a point-in-time snapshot (March 2020) of the number of individuals, by institution, on OAT and the number of individuals on the wait list.
For the Atlantic region: For the Quebec region: For the Ontario Region: For the Prairies region: For the Pacific Region: In total, there are 779 on methadone, 1281 on suboxone, 95 on sublocade. The OAT totals are 2155 and there are 447 on waitlist.
Page details
- Date modified: